Skip to main content

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 7))

Abstract

Gastric toxicity of non-steroidal antiinflammatory drugs has been suggested to be due to inhibition of prostaglandin synthesis. Proquazone, which is less ulcerogenic than indomethacin, however, is a more potent inhibitor of gastric mucosal prostaglandin synthesis than indomethacin in vitro and equally effective in vivo. These results indicate that additional factors such as pharmacokinetic properties contribute to the gastric toxicity of non-steroidal antiinflammatory drugs. Furthermore, lipoxygenase products of arachidonic acid metabolism might modulate the effects of inhibition of prostaglandin synthesis by non-steroidal antiinflammatory drugs. Using a radioimmunoassay for leukotriene C4 the capacity of ovalbumin-sensitized guinea pig gastric mucosa to release leukotriene C4-like immunoreactivity after antigenic challenge has been demonstrated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aehringhaus U, Wölbung RH, König W, Patrono C, Peskar BM, Peskar BA (1982) Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett 146: 111–114

    Article  PubMed  CAS  Google Scholar 

  • Allen R, Bleicher M (1977) Die Behandlung degenerativer Gelenkerkrankungen mit Biarison. Schweiz Rundschau Med 46: 1481–1489

    Google Scholar 

  • Augstein J, Farmer JB, Lee TB, Sheard P, Tattersall ML (1973) Selective inhibitor of slow-reacting substance of anaphylaxis. Nature (New Biol) 245: 215–217

    Article  CAS  Google Scholar 

  • Bennett A, Hensby CN, Sanger GJ, Stamford IF (1981) Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br J Pharmacol 74:435–444

    PubMed  CAS  Google Scholar 

  • Brune K, Gubler H, Schweitzer A (1979) Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacol Ther 5: 199–207

    Article  CAS  Google Scholar 

  • Gubler HU, Baggiolini M (1978) Pharmacological properties of proquazone. Scand J Rheumatol 21:8–11

    Article  CAS  Google Scholar 

  • Liebig R, Bernauer W, Peskar BA (1974) Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines. Naunyn-Schmiedebergs Arch Pharmacol 284:279–293

    Article  PubMed  CAS  Google Scholar 

  • Morris HR, Piper PJ, Taylor GW, Tippins JR (1980) The role of arachidonate lipoxygenase in the release of SRS-A from guinea-pig chopped lung. Prostaglandins 19: 371–383

    Article  PubMed  CAS  Google Scholar 

  • Peskar BM (1977) On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim Biophys Acta 487: 307–314

    PubMed  CAS  Google Scholar 

  • Peskar BM, Seyberth HW, Peskar BA (1980) Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res 8: 1511

    PubMed  CAS  Google Scholar 

  • Peskar BM, Weiler H, Peskar BA (1982) Effect of BW 755C on prostaglandin synthesis in the rat stomach. Biochem Pharmacol 31: 1652–1653

    Article  PubMed  CAS  Google Scholar 

  • Takesue EI, Perrine JW, Trapold JH (1976) The antiinflammatory profile of proquazone. Arch Int Pharmacodyn 221: 122–131

    PubMed  CAS  Google Scholar 

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 231: 232–235

    CAS  Google Scholar 

  • Weiler H, Meier C, Fröhlich J, Peskar BM (1984) Effect of proquazone and indomethacin on gastric prostaglandin synthesis in vitro and in vivo. Agents Actions (in press)

    Google Scholar 

  • Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR (1980) Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284:271–273

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag

About this paper

Cite this paper

Aehringhaus, U., Weiler, H., Peskar, B.A., Peskar, B.M. (1984). Molecular Mechanisms of the Gastric Toxicity of Antirheumatic Drugs. In: Chambers, P.L., Preziosi, P., Chambers, C.M. (eds) Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals. Archives of Toxicology, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69132-4_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69132-4_55

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-12452-8

  • Online ISBN: 978-3-642-69132-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics